Kornerup Linda Skibsted, Gluud Lise Lotte, Vilstrup Hendrik, Dam Gitte
Department of Hepatology and Gastroenterology, Aarhus University Hospital, 44 Norrebrogade, 8000, Aarhus, Denmark.
Gastrounit, Medical Division, Copenhagen University Hospital, Kettegaard Allé 30, Hvidovre, 2650, Denmark.
Curr Gastroenterol Rep. 2018 Apr 11;20(5):21. doi: 10.1007/s11894-018-0627-8.
Hepatic encephalopathy (HE) is a common and devastating complication to chronic liver disease. In this paper, we summarize the latest research and evidence of both conventional and up-coming treatments.
Meta-analyses report beneficial effects of lactulose, branched-chain amino acids, rifaximin, and to some degree L-ornithine L-aspartate on the manifestations of HE in patients with cirrhosis, and generally the numbers needed to treat are low. Recent studies on newer HE treatments including ornithine phenylacetate, spherical carbon, and fecal microbiota transplant also report potentially beneficial effects on HE manifestations. The conventional treatments benefit patients with HE. Newer treatments are under study and more research is needed for their validation.
肝性脑病（HE）是慢性肝病常见且严重的并发症。在本文中，我们总结了传统治疗方法和新兴治疗方法的最新研究及证据。
荟萃分析报告了乳果糖、支链氨基酸、利福昔明以及在一定程度上L-鸟氨酸L-天冬氨酸对肝硬化患者HE表现的有益作用，且通常治疗所需人数较少。近期关于包括鸟氨酸苯乙酸、球形碳和粪便微生物群移植等新型HE治疗方法的研究也报告了对HE表现可能有益的作用。传统治疗方法对HE患者有益。新型治疗方法正在研究中，需要更多研究来验证其效果。
